We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Impact of Recombinant Human Growth Hormone on HIV Persistence

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03091374
Recruitment Status : Active, not recruiting
First Posted : March 27, 2017
Last Update Posted : March 15, 2023
EMD Serono
Information provided by (Responsible Party):
Jean-Pierre Routy, McGill University Health Centre/Research Institute of the McGill University Health Centre